首页> 外文OA文献 >Biobanking in health care: evolution and future directions
【2h】

Biobanking in health care: evolution and future directions

机译:生物库在医疗保健中:进化和未来方向

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Abstract Background The aim of the present review is to discuss how the promising field of biobanking can support health care research strategies. As the concept has evolved over time, biobanks have grown from simple biological sample repositories to complex and dynamic units belonging to large infrastructure networks, such as the Pan-European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI). Biobanks were established to support scientific knowledge. Different professional figures with varied expertise collaborate to obtain and collect biological and clinical data from human subjects. At same time biobanks preserve the human and legal rights of each person that offers biomaterial for research. Methods A literature review was conducted in April 2019 from the online database PubMed, accessed through the Bibliosan platform. Four primary topics related to biobanking will be discussed: (i) evolution, (ii) bioethical issues, (iii) organization, and (iv) imaging. Results Most biobanks were founded as local units to support specific research projects, so they evolved in a decentralized manner. The consequence is an urgent needing for procedure harmonization regarding sample collection, processing, and storage. Considering the involvement of biomaterials obtained from human beings, different ethical issues such as the informed consent model, sample ownership, veto rights, and biobank sustainability are debated. In the face of these methodological and ethical challenges, international organizations such as BBMRI play a key role in supporting biobanking activities. Finally, a unique development is the creation of imaging biobanks that support the translation of imaging biomarkers (identified using a radiomic approach) into clinical practice by ensuring standardization of data acquisition and analysis, accredited technical validation, and transparent sharing of biological and clinical data. Conclusion Modern biobanks permit large-scale analysis for individuation of specific diseases biomarkers starting from biological or digital material (i.e., bioimages) with well-annotated clinical and biological data. These features are essential for improving personalized medical approaches, where effective biomarker identification is a critical step for disease diagnosis and prognosis.
机译:摘要背景本次审查的目的是讨论生物银行的看好领域如何支持医疗保健研究策略。由于概念已经随着时间的演变,生物银行已经从简单的生物样本资源库属于大型基础设施网络,如泛欧洲生物银行和生物分子资源研究基础设施(BBMRI)复杂和动态的单位增长。生物样本库的建立是为了支持科学知识。具有不同专长协作不同的专业数据获取和收集来自人类受试者的生物和临床数据。在同时生物库维护人类和每个人的提议的生物材料研究的合法权益。方法文献回顾在4月2019联机数据库考研,通过Bibliosan平台访问进行。 4个涉及生物样本库的主要议题将被讨论:(一)发展,(二)生物伦理问题;(三)组织,及(iv)成像。结果大多数生物银行都成立地方单位的支持,具体的研究项目,所以他们以分散的方式演变。其后果是迫切需要的程序协调有关样品的采集,处理和存储。考虑到从人类获得的生物材料的参与,不同的伦理问题,如知情同意模型,样品所有权,否决权和生物样本库的可持续性存在争议。在这些方法和伦理挑战面前,国际组织,如BBMRI在支持生物样本库的活动中起关键作用。最后,独特的发展是成像通过确保数据采集和分析,认证技术验证,以及生物学和临床数据的透明共享的标准化支持成像的生物标志物的翻译(使用radiomic方法识别)到临床实践生物库的创建。结论现代生物库允许用于从生物或数字材料(即,bioimages)与注释良好的临床和生物学数据开始特定疾病的生物标志物的个性化大规模分析。这些特征可用于改进的个性化医疗方法,其中有效生物标记鉴定为疾病的诊断和预后中的关键步骤是必不可少的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号